Other

Total accrued rebates and other sales-related accruals

Pfizer Total accrued rebates and other sales-related accruals decreased by 1.0% to $11.55B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_rebates_and_other_sales_related_accruals

Historical Data

2 periods
 Q4 '25Q1 '26
Value$11.67B$11.55B
QoQ Change—-1.0%
Range$11.55B – $11.67B

Frequently Asked Questions

What is Pfizer's total accrued rebates and other sales-related accruals?
Pfizer (PFE) reported total accrued rebates and other sales-related accruals of $11.55B in Q1 2026.